| scholarly article | Q13442814 |
| P50 | author | Fernando de Assis Batista | Q56797747 |
| Fernando A. Soares | Q43653328 | ||
| Jose Vassallo | Q45738317 | ||
| P2093 | author name string | Laura Sterian Ward | |
| Lucas Leite Cunha | |||
| Mariana Bonjiorno Martins | |||
| Marjory Alana Marcello | |||
| Elaine Cristina Morari | |||
| P2860 | cites work | Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes | Q24680097 |
| Structure, chromosomal localization, and expression of 12 genes of the MAGE family | Q28238754 | ||
| Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer | Q28262641 | ||
| Cancer/testis antigens, gametogenesis and cancer | Q29616129 | ||
| Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses | Q33617905 | ||
| Epigenetic control of MAGE gene expression by the KIT tyrosine kinase | Q34627523 | ||
| Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma | Q34743450 | ||
| Cancer/testis-associated genes: identification, expression profile, and putative function | Q35053915 | ||
| Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial | Q36642308 | ||
| Cancer/testis (CT) antigens: potential targets for immunotherapy | Q37589698 | ||
| Emerging immunotherapies for renal cell carcinoma | Q38037491 | ||
| Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus. | Q38119437 | ||
| MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter | Q73011565 | ||
| mRNA expression of MAGE-A3 gene in leukemia cells | Q79808841 | ||
| Muc-1 expression may help characterize thyroid nodules but does not predict patients' outcome | Q82352404 | ||
| Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer | Q83772208 | ||
| Expression of MAGE tumor-associated antigen in thyroid carcinomas | Q83947432 | ||
| MAGE, biological functions and potential clinical applications | Q84186257 | ||
| Vaccination therapy for non-small-cell lung cancer. | Q38179886 | ||
| The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer | Q40093718 | ||
| Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo | Q40234218 | ||
| MAGE-A3-specific anticancer immunotherapy in the clinical practice | Q42908403 | ||
| Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. | Q44985713 | ||
| Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer. | Q51786346 | ||
| Cancer/testis (CT) antigens - a new link between gametogenesis and cancer | Q52105492 | ||
| The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. | Q53450205 | ||
| Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. | Q54790876 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 921864 | |
| P577 | publication date | 2014-11-04 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors | |
| P478 | volume | 2014 |
Search more.